Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers

NCT04952506 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Renal Failure

Interventions

DRUG: CKD-349 F1 Tab.
DRUG: CKD-349 F2 Tab.
DRUG: D113 Tab.

Sponsor

Chong Kun Dang Pharmaceutical